HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
September 6, 20241h 2m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Prof Peter Schmid and Dr Sara M Tolaney, including the following topics:
- Introduction: Pharmacology and Sequencing of Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC) (0:00)
- Expanding Role of TROP2-Directed ADCs in mBC Management — Dr Tolaney (21:42)
- Other Targets for ADC Therapy in mBC — Prof Schmid (44:59)